2015 MDEA Jurors
Judging of each year’s MDEA competition is conducted by an impartial, multidisciplinary panel of expert jurors—comprised of a balance of clinicians, engineers, and designers—who carefully review all of the submissions and narrow them down to a select group of exceptional products in each of the 11 medtech categories. The jury panel typically encompasses medtech professionals from a wide range of healthcare and design related fields, including clinical practice, biomedical engineering, human factors, industrial design, manufacturing, and other areas.
Members of the MDEA jury are selected each year by a panel of editors from UBM Canon. Such independence and impartiality is a leading reason for the industry wide acceptance and success that the MDEA program has enjoyed. MDEA jurors—past and present—have set a high standard for judging excellence and fair competition.
Watch these two videos featuring MDEA Jurors:
- 2014 Jurors discuss trends among the 2014 MDEA Finalists
- 2013 Jurors discuss the MDEA's 15th Anniversary
- The MDEA Program in the Jurors' Own Words
Meet the 2015 MDEA Jurors. Please check back as we update with new jurors.
Edward G. Chekan, MD, FACS—Dr. Chekan is a board-certified general surgeon with fellowship training in minimally invasive surgery. He completed his general surgery residency at Allegheny General Hospital in 1997, and then went on to Duke University for a two year fellowship in minimally invasive surgery. From Duke, he move to Charlottesville, VA for three years as an Assistant Professor of Surgery at The University of Virginia where he was very active in training of laparoscopic fellows, surgical residents and medical students. From UVA, he moved to Pittsburgh as a private practice surgeon. Early in 2007, he joined Ethicon Endo-Surgery in Cincinnati, OH. As a Medical Director in Medical Affairs, he is a member of multiple product development teams and functions as a subject matter expert and scientific advisor. In addition to publishing several journal articles and book chapters on minimally invasive surgery, he has co-edited a textbook entitled The Atlas of Laparoscopic Surgery. He is a fellow of The American College of Surgeons (FACS) and a member of The Society of Gastrointestinal and Endoscopic Surgeons (SAGES), The American Society of Metabolic and Bariatric Surgeons (ASMBS) and The Southeastern Surgical Congress (SESC).
Edward G. Chekan, MD, FACS | Medical Director, WW Medical Affairs | Johnson and Johnson Global Surgery Group | 4545 Creek Rd. | Cincinnati, OH 45242 |Phone: 513-659-3272; 513-337-8160 | E-mail: email@example.com; firstname.lastname@example.org | Twitter: @edchekan | Linkedin: www.linkedin.com/in/edwardchekanmd | WordPress: www.edchekan.wordpress.com
Yadin B. David—Dr. David is the founder of Biomedical Engineering Consultants LLC, a Houston firm that provides assessment of life-cycle medical technology management, regulatory compliance and forensic engineering services to hospitals, industry and litigators worldwide. For the previous 25 years, Dr. David headed the biomedical engineering department and the Center for Telehealth at the largest medical center in the country (Houston). He holds academic appointment at the University of Texas, School of Public Health. Dr. David has been a member and currently chairman of FDA advisory panel and is the recipient of the FDA commissioner’s special citation. He also received the ACCE/AAMI Robert L. Morris Humanitarian Engineering award, ACCE Life time achievement award, the 2014 Distinguished Professional Achievement and Service award, and the 2013 distinguish leadership Award from the Medical Engineering Society of China. He has also served as an adviser to the World Health Organization (WHO), and as president of the Center for Telemedicine and eHealth Law (CTeL). He is a member of the Electrical Safety, EMC and MDDS WG committees of the Association for the Advancement of Medical Instrumentation (AAMI). He is a fellow of the American College of Clinical Engineering (ACCE); of the American Institute for Medical and Biological Engineering (AIMBE), of the Healthcare Technology Task Group of the International Union for Physical & Engineering Sciences in Medicine (IUPESM), a senior member of the Institute of Electrical and Electronics Engineers (IEEE); and of the clinical engineering division of the International Federation of Medical and Biological Engineering (IFMBE). David holds a BSc in electrical engineering, an MSc in biomedical engineering, and an EdD in education from West Virginia University. He is a diplomat of the American Board of Forensic Engineering and Technology, is registered as a professional engineer, and is certified as a clinical engineer. He is also president emeritus of the nonprofit Healthcare Technology Foundation (www.thehtf.org). He has published numerous manuscripts and books. His areas of expertise include biomedical engineering, risk mitigation, telemedicine, electromagnetic interference, medical equipment evaluation, and incidents investigation.
Craig M. Jackson, PhD—Dr. Jackson is the retired president of Hemosaga Diagnostics Corp., a start-up company in San Diego. He now operates a San Diego–based consulting practice and serves as the Program Director for The Hartwell Foundation, a foundation supporting innovative, high risk research related to diseases of children. Jackson has served as president and director of research and development for Reagents Applications Inc. and as scientific director for the American Red Cross Blood Services (Detroit) where he was also an adjunct professor of biochemistry at Wayne State University. He was a professor of biological chemistry and an associate professor of internal medicine at Washington University School of Medicine (St. Louis) prior to joining the American Red Cross. He has been a visiting professor at Kyushu University (Fukuoka, Japan) and the University of Hawaii. Jackson is a member of the editorial advisory board for IVD Technology magazine. He has written more than 75 original papers, contributed to more than 30 textbooks, writes regularly for both professional and trade journals, and holds several patents. He is a member of Working Group 1 of the Joint Committee for Traceability in Laboratory Medicine (JCTLM), an organization founded by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), the Bureau International des Poids et Mesures (BIPM), and the International Laboratory Accreditation Cooperation (ILAC). JCTLM provides the mechanism by which the European Union’s In Vitro Device Directive requirement for traceability can be met. On the JCTLM, Jackson has led the team that has developed the quality system. He served on the USP Ad Hoc Advisory Committee on Heparin during the heparin adulteration crisis of 2008-2009. Jackson received a BS degree from Washington State University (Pullman, WA) and a PhD from the University of Washington (Seattle). He is a fellow of the National Academy of Clinical Biochemistry (Washington, DC) and also a fellow of the American Association for the Advancement of Science (Washington, DC).
Craig M. Jackson, PhD | Consultant for In Vitro Diagnostics, Hemostasis Testing, and Quality Systems for Laboratory Medicine | 5931 Seacrest View Rd. | San Diego, CA 92121-4355 | 858-638-0957 | email@example.com
Stuart Karten—Stuart Karten is the President of the award-winning Los Angeles-based product design and innovation consultancy, Karten Design. For 30 years, he has partnered with medical device and consumer electronics companies, from start-ups to Fortune 500 companies, to seize new business opportunities, commercialize new technology, and develop differentiated products that create positive experiences for the people who use them. His designs, which include easy-to-use emergency defibrillators, clinical equipment that saves physicians’ time, and hearing aids that banish stigma, are developed to improve adoptability and advance the standard of care. Stuart is a graduate of the Rhode Island School of Design. He worked for Gould Medical Products, Mattel, and Baxter Medical Products until founding Karten Design.
Stuart Karten | Principal | Karten Design | 4204 Glencoe Ave. | Marina Del Rey, CA 90292 | 310-827-8722 | firstname.lastname@example.org | www.kartendesign.com | @StuartKarten | www.linkedin.com/in/kartendesign
Raj Khandwalla, MD, MA, FACC—Dr. Khandwalla is a board-certified cardiologist practicing with the Cedars-Sinai Medical Group (CSMG) and Cedars-Sinai Heart Institute. Dr. Khandwalla earned a bachelor's degree in molecular cell biology with an emphasis in neurobiology from the University of California, Berkeley. He earned his medical degree from the Tufts University School of Medicine and a master's degree in international relations from the Fletcher School of Law and Diplomacy. He completed his residency training at New York University (NYU) Medical Center, where he served as chief resident. At NYU, he developed web-based educational tools and helped to found the award-winning clinicalcorrelations.org. More recently, Dr. Khandwalla completed a cardiology fellowship at Georgetown University Hospital and Washington Hospital Center where he developed social networking software to improve communication and enable physicians to share information.
As an attending cardiologist at Cedars-Sinai Heart Institute, Dr. Khandwalla is currently a co-investigator in the NIH funded R-WISE study and is using wireless activity monitors to track the effectiveness of targeted therapies for women with microvascular dysfunction. In addition, he is co-director of the CSMG Heart Failure Program which has pioneered the use of biomarkers and handheld ultrasound to optimize therapy and reduce hospital re-admission rates.
Dr. Khandwalla has co-authored research papers on heart failure and has conducted research on mitral valve disease. He has an avid interest in developing strategies for effective lifestyle modification by using mobile technology to help patients monitor and change their habits in order to reduce their cardiovascular risk.
Raj Khandwalla, MD, MA, FACC | Cardiologist | Cedars-Sinai Medical Center | 250 N. Robertson Blvd., Suite 403 | Beverly Hills, CA 90048 | 310-385-3496 | email@example.com | @rajkmd | www.cedars-sinai.edu/Raj-Khandwalla-MD| www.linkedin.com/pub/raj-khandwalla-m-d-m-a/25/197/474
Stephanie Kreml, MD—Dr. Kreml’s broad career spans across medicine, engineering and business development. As Principal at Popper and Company, she develops business strategies and provides guidance to accelerate new product development for medical device companies. She is also a guest columnist for InformationWeek Healthcare, providing thought leadership on various topics related to digital health.
Dr. Kreml received her Doctor of Medicine from the Baylor College of Medicine and continues to practice part-time in the urgent care setting. Prior to medical school, she received a Bachelor of Science in Electrical Engineering from The University of Texas at Austin and held engineering positions in the semiconductor industry. During her residency in general surgery, she was a research fellow at Baylor College of Medicine’s Human Genome Sequencing Center and in the Mechatronics and Haptic Interfaces Lab at Rice University.
Stephanie Kreml, MD | Principal | Popper and Company | PO Box 163721 | Austin, Texas 78716 | 512-658-0048 | firstname.lastname@example.org | @SKremlMD | www.popperandco.com | www.linkedin.com/pub/stephanie-kreml-md/7/a23/202
Jonathan Y. Lee, MD, ABEM—Dr. Lee is the Quality Improvement Director at Scripps Mercy Hospital, a tertiary care, level-one trauma center, in San Diego. He has served as the Chairperson of the Emergency Medicine Department and Education Director. Dr. Lee has had varied experiences in his career. He has volunteered for numerous disasters and charities including International Relief Team, International Latin American Concerns, Scripps Medical Relief Team, and Disaster Medical Relief Team at federal and state level among others. With expertise and training in Tropical Medicine, he has traveled extensively to provide medical care to third world countries. He has a strong affinity for teaching, and has been the recipient of numerous awards as the best educator by multiple institutions. He has also been honored by his peers as one of the top doctors in San Diego County, California. His current interests include behavioral decision making processes in medicine, and application of ultrasound in community hospital emergency departments. Additionally, his facility in clinical medicine and current patent work in medical devices confers him an appropriate perspective as an MDEA juror.
Jonathan Y. Lee, MD, ABEM | Quality Improvement Director | Scripps Mercy Hospital | 4077 Fifth Ave. | San Diego, CA 92103 | USA | 619-686-3800 | email@example.com
Pascal Malassigné, FIDSA—Mr. Malassigné is the senior professor and chair of industrial design at the Milwaukee Institute of Art and Design, a career research scientist and industrial designer at the Milwaukee Veterans Affairs Medical Center, and an adjunct assistant professor of rehabilitation at the Medical College of Wisconsin in Milwaukee. He is one of the nation’s foremost designers of assistive and wheeled mobility for the elderly and those with disabilities. For over 25 years, his research has been funded by the U.S. Department of Veterans Affairs and has led to the design of patented products from commode-shower wheelchairs to bathing fixtures, mobility carts for spinal cord injured individuals. Malassigné has 40 years of experience teaching industrial design, and taught at Georgia Tech and Virginia Tech universities before coming to Milwaukee in 1991. He is a visiting evaluator for the National Association of Schools of Art & Design, for the accreditation of industrial design programs. He has authored more than 70 articles and papers and has made numerous presentations nationally and internationally on topics ranging from design education to rehabilitation technology. Malassigné is a member of the Human Factors and Ergonomics Society, the Rehabilitation Engineering Society of North America, and the Industrial Designers Society of America (IDSA), in which he was made a fellow member in 2001 in honor of his service to the industrial design profession and IDSA. He was the first president of the Design Foundation, IDSA’s nonprofit organization. In 2006, Design Intelligence named him one of the nation’s most admired industrial design educators.
Pascal Malassigné, FIDSA | Senior Professor & Chair, Industrial Design | Milwaukee Institute of Art & Design | 273 E. Erie St. | Milwaukee, WI 53202 | 414-291-8069 | firstname.lastname@example.org | www.miad.edu | www.linkedin.com/pub/pascal-malassigné-fidsa/2/741/398
Craig Scherer—Craig is senior partner and co-founder of Insight Product Development, a design innovation consultancy in Chicago. Since 1988, Insight has grown into a leading design firm that serves companies globally in a variety of healthcare spaces including: medical services, systems and devices, pharmaceutical delivery systems, and laboratory and life science platforms. Craig maintains an active role in project management, working with technology-centric medical companies ranging from start-ups to the Fortune 50. He is also a director of Insight Accelerator Labs which he co-founded in 2013 to help med tech start-ups evolve their technology in order to bridge the gap between bench top solutions and proven clinical applications. Craig played an active role on the teams that earned Insight, 6 MDEA awards including the XCat mobile CT scanner, the Hill-Rom Patient Surface Controller, the Alyx, Aphaeresis Blood Collection System for Fenwal, and St. Jude Medical’s Merlin.net Patient Care Network. Craig is an active presenter and editorial contributor on topics such as, the role of user-centered design in wireless healthcare, balancing user capability with device complexity in pharmaceutical delivery devices, and technology and development best practices for med tech startups, among others. Craig holds a BFA in industrial design from the University of Illinois at Urbana-Champaign and an MBA from the University of Illinois at Chicago.
George L. Walls—George Walls is the Head of Marketing for ZOLL, an Asahi Kasei Group company. For over 25 years he has led innovation teams across multiple disciplines to develop, launch, and market advanced technology and medical devices. He is passionate about cross-functional excellence that results in the delivery of “whole products” combining devices, services, training, and support to create meaningful user experiences and life-saving outcomes. Today his portfolio includes tools for critical care and includes Intravascular Temperature Management and a Cardiopulmonary bypass system. Functionally, he leads upstream marketing, human factors engineering, and reimbursement planning. George is a prior MDEA winner and previously worked for St. Jude Medical and Laerdal Medical Corporation. He holds several patents on medical devices, a BS/BA from the University of Dayton and an Executive MBA from the University of Houston.
ZOLL Medical Corporation, an Asahi Kasei Group company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and critical care. For more information, visit www.zoll.com.
George L. Walls | Director, Product and Market Development | ZOLL | 2000 Ringwood Avenue | San Jose, CA 95131 | USA | 408-541-2140| email@example.com | www.zoll.com | www.linkedin.com/pub/george-walls/0/54/547/
Michael E. Wiklund, PE, CHFP—Mr. Wiklund is General Manager of UL’s human factors engineering practice (formerly Wiklund Research & Design Inc. in Concord, MA). The group helps companies develop safe, effective, usable, and appealing medical products. Board-certified in his profession, Wiklund’s experience as a project manager, principal researcher, and designer extends beyond medical devices to include consumer and scientific products, personal and business software, corporate and e-commerce Web sites, communications technology, and industrial equipment and workplaces. As Professor of the Practice at Tufts University, heteaches courses on human factors in medical technology and software user interface design. Wiklund has been a contributing editor to Medical Device and Diagnostic Industry magazine (MD&DI) since 1993, and is a member of the publication’s editorial advisory board. He has published numerous articles, books, and technical papers, and has also presented papers at professional conferences in the medical device, human factors, and scientific instrumentation fields. He co-authored Usability Testing of Medical Devices and Designing Usability into Medical Products and co-edited Handbook of Human Factors in Medical Device Design. He is a voting member of the AAMI and IEC human factors engineering committees. Holding BS (civil engineering) and MS (engineering design/human factors) degrees from Tufts University, Wiklund is also a professional engineer. In 2004, MD+DI named Wiklund to its list of 100 notable people in the medical device industry.
Michael E. Wiklund, PE, CHFP | General Manager – Human Factors Engineering | UL–Wiklund R&D | 152 Commonwealth Ave. | Concord, MA 01742 | Phone: 978-371-2700 | firstname.lastname@example.org | www.wiklundrd.com
Marta Gaia Zanchi, PhD— Dr. Zanchi is Founder and Managing Director of Medinnovo LLC, a consultancy firm established to support the entrepreneurial community of Silicon Valley, and Lecturer with Stanford University's School of Medicine in the Biodesign Program, where she participates in the planning activities of the Biodesign Leadership Group and co-directs "Biodesign for Mobile Health," an entrepreneurial course. Under Medinnovo, Dr. Zanchi has worked as consultant, advisor or Board member with companies in the cardiovascular, imaging and mobile health industry, for some in acting executive positions joining the leardership teams at critical times of the company’s early growth. She is an advisor to student teams at Stanford University and a mentor at StartX, a startup accelerator. In previous years, Dr. Zanchi was the Chief Executive Officer of RenovoRx, an EIR with The Angels Forum (TAF), the co-chair of the Connected Health Safety Initiative (CHSI), a Medical Device Fellow with the U.S. Food and Drug Administration (FDA), and has held positions as system design and product management engineer with privately held semiconductor and wireless technology startups. Dr. Zanchi is a top graduate in biomedical engineering (BS) and electrical engineering (MS, PhD) from Politecnico Di Milano (Italy) and Stanford University. Her work at both universities focused on the development of innovative medical devices and systems for the diagnosis and staging of diseases. She was awarded the Politecnico Di Milano's highest student honor and two fellowships from Stanford University. She was trained in entrepreneurship (Ignite) and holds an award from the Stanford Graduate School of Business.
Marta Gaia Zanchi | Lecturer, School of Medicine, Biodesign Program | Stanford University | Founder, Managing Director| Medinnovo LLC | 333 West Santa Clara Street, Suite 900 | San Jose, CA 95113 | E-mail: email@example.com; firstname.lastname@example.org | Twitter: @medinnovo | Linkedin: www.linkedin.com/in/mgzanchi | Website: www.medinnovo.com